Jump to Navigation

Top Matters

Bracewell Represents Syntrix in $115 Million DNA Patent Suit

March 18, 2013

HOUSTON -- Bracewell & Giuliani LLP won a federal jury verdict in a patent suit on behalf of Syntrix, a biotechnology research firm, against Illumina in the U.S. District Court for the Western District of Washington before U.S. District Judge Benjamin H. Settle.

Syntrix first filed the suit in November 2010, alleging that Illumina's sales of its BeadChip products infringed U.S. Patent 6,951,682. After an 11 day trial, the jury awarded Syntrix $95,795,507 in damages and a 6 percent royalty rate. When the final judgment was entered in June 2013, Syntrix was awarded a total of $115,106,105, which included the verdict plus prejudgment interest of $7,273,130, and supplemental damages in the amount of $12,037,468.  Additionally, Syntrix was awarded an ongoing royalty at the rate of 8 percent per infringing future sale.

Bracewell attorneys who worked on this matter include:

Partners: Alan D Albright and Michael R. Samardzija

Associates: Heather Khassian, Karthika Perumal, and Lucy Tyson

Bracewell attorneys were also assisted by attorneys from Nix, Patterson & Roach: Derek Gilliland, Ed Chin, Andrew Wright, and Winn Cutler.